. 2022 Apr 11;49(7):2300–2309. doi: 10.1007/s00259-022-05785-x

Table 1.

Physical characteristics of the commonly used theranostics pairs ⁶⁸ Ga/¹⁷⁷Lu and ⁶⁸ Ga/⁹⁰Y

Radionuclides	Physical characteristics*			Pharmaceuticals^†
	Energy [keV]		Half-life
	Gamma	Beta or Alpha
⁶⁸Ga	511 (caused by annihilation)	1899 ( $β$ ⁺)	1.13 h	[⁶⁸Ga]Ga-PSMA-11 [⁶⁸Ga]Ga-PSMA-I&T [⁶⁸Ga]Ga-DOTA-TATE (NETSPOT ™) [⁶⁸Ga]Ga-DOTA-TOC (SomaKIT TOC ®)	Diagnostic
¹⁸F	511 (caused by annihilation)	634 ( $β$ ⁺)	1.83 h	Piflufolastat F18 (Pylarify®) [¹⁸F]F PSMA-1007 [¹⁸F]DCFPyL	Diagnostic
¹⁷⁷Lu	113 (6%) 208 (11%)	498 ( $β$ ⁻)	6.73 d	[¹⁷⁷Lu]Lu-PSMA-617 [¹⁷⁷Lu]Lu-PSMA-I&T [¹⁷⁷Lu]Lu-DOTA-TATE (Lutathera®)	Therapy
⁹⁰Y	Bremsstrahlung	2280 ( $β$ ⁻)	2.67 d	[⁹⁰Y]Y-DOTA-TOC	Therapy
^99mTc	140 (89%)	not relevant	6.01 h	[^99mTc]Tc-MDP [^99mTc]Tc-DPD [^99mTc]Tc-HDP	Diagnostic
²²³Ra	154 (6%) 269 (14%)	5716 ( $α$ ), 5606 ( $α$ ), 6819 ( $α$ ), 7386 ( $α$ ), 6623 ( $α$ ) 1370 ( $β$ ⁻) 1420 ( $β$ ⁻)	11.44 d	²²³RaCl₂ (Xofigo ®)	Therapy

^*Data are extracted from The Lund/LBNL Nuclear Data Search V 2.0 (http://nucleardata.nuclear.lu.se/toi/)

^†Without claim to completeness